Clinical Trial Update: Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults [Phase 3]

View source ↗

Summary

A Phase 3 booster study of a combined Diphtheria-tetanus-acellular Pertussis vaccine in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Diphtheria-tetanus-acellular Pertussis Vaccine (DTaP) (Diphtheria-tetanus-acellular pertussis vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria, Pertussis | Phase 3 | Status: COMPLETED